Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
Status:
Terminated
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of rebeccamycin analogue in treating
patients who have advanced liver and/or biliary cancer.